Logo
O

Oblique Therapeutics

23 employees

Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
drug development
advanced cancer
pain
Medical
Health Care
biotech
Hospital
antibody

Date founded

2015

Funding rounds raised

Total raised

$2.5M

from 1 investors over 1 rounds

O

Oblique Therapeutics raised $2.5M on December 11, 2015

Investors: Almi Invest

FAQ